News + Events
NIAID/NIH guidelines, May 20th 3PM

VMX 2024, January 13 – 17

Indiana Veterinary Medical Association (IVMA), February 1 – 3

Midwest Veterinary Conference, February 22 – 24

Visit MiraVista Veterinary Diagnostics At VMX 2023 | Booth #5035
Representatives from MiraVista Veterinary Diagnostics will attend VMX 2023 in Orlando, Florida, from January 14th - January 18th. Visitors to our booth can register to win a BarkBox or meowbox giveaway. Our booth number is #5035. A map of the Orange County Conference...

MiraVista Partnered with DVM360 to Sponsor a 1-hr RACE® Approved Course
MiraVista partnered with DVM360 to sponsor a 1-hr RACE® approved course on antifungal therapy in small animals. Key Learning Objectives: Treatment of choice for common invasive fungal infections. Monitoring antifungal treatment to avoid adverse effects. Available...

VETgirl Podcast: Endemic Mycoses and Treatment
Dr. Hanzlicek presented a podcast on VETgirl, discussing endemic mycoses and treatment. Click the links below to listen to the presentation. On iTunes/Apple podcasts On our website

MiraVista – VetGirl
Dr. Andrew Hanzlicek presented a 1-hour webinar on VetGirl, discussing clinical review of antifungal treatment recommendations for common invasive fungal infections in dogs and cats, including blastomycosis, histoplasmosis, coccidioidomycosis, cryptococcosis, and...

Test Report Updates for 2021
In order to maintain good business practices, MiraVista Diagnostics is providing a 90-day notice of pending updates to our referral testing customers. Beginning March 1, 2021 MiraVista Diagnostics will transition to an improved MVista® Histoplasma Antigen Quantitative...
Test Report Updates for 2020
MiraVista COVID-19 Announcement
Saturday Testing and Shipments
Updates to Our Hours of Operation

MiraVista to Receive Economic Incentives from IEDC for Expansion
Indiana Economic Development Corporation Offers $325,000 in economic incentives to MiraVista. This includes $275,000 in tax credits and $50,000 in training grants to hire additional employees and expand its corporate headquarters and diagnostic laboratory in Indianapolis.